UPDATE -- Rain Therapeutics Announces Completion of Enrollment in Phase 3 MANTRA Trial for Milademetan in Liposarcoma

04.08.2022 - – Phase 3 MANTRA trial completed enrollment five months ahead of previous guidance – – MANTRA topline data anticipated in 1H 2023 – – Management to host 2Q 2022 Earnings Call today at 5:00 PM Eastern Time – NEWARK, Calif., Aug. 04, 2022 ... Seite 1

Related Keywords

Richard Bryce ,Avanish Vellanki ,Rain Therapeutics Inc ,